nodes	percent_of_prediction	percent_of_DWPC	metapath
Agomelatine—Angioedema—Chlorambucil—testicular cancer	0.00775	0.00775	CcSEcCtD
Agomelatine—Irritability—Cisplatin—testicular cancer	0.00766	0.00766	CcSEcCtD
Agomelatine—Rash erythematous—Epirubicin—testicular cancer	0.00742	0.00742	CcSEcCtD
Agomelatine—Nasopharyngitis—Cisplatin—testicular cancer	0.00718	0.00718	CcSEcCtD
Agomelatine—Infestation—Ifosfamide—testicular cancer	0.00718	0.00718	CcSEcCtD
Agomelatine—Infestation NOS—Ifosfamide—testicular cancer	0.00718	0.00718	CcSEcCtD
Agomelatine—Hepatitis—Dactinomycin—testicular cancer	0.00703	0.00703	CcSEcCtD
Agomelatine—Vertigo—Vinblastine—testicular cancer	0.00698	0.00698	CcSEcCtD
Agomelatine—Infection—Chlorambucil—testicular cancer	0.00687	0.00687	CcSEcCtD
Agomelatine—Rash erythematous—Doxorubicin—testicular cancer	0.00686	0.00686	CcSEcCtD
Agomelatine—Hepatobiliary disease—Ifosfamide—testicular cancer	0.00679	0.00679	CcSEcCtD
Agomelatine—Hepatitis—Ifosfamide—testicular cancer	0.00644	0.00644	CcSEcCtD
Agomelatine—Hallucination—Ifosfamide—testicular cancer	0.00641	0.00641	CcSEcCtD
Agomelatine—Connective tissue disorder—Ifosfamide—testicular cancer	0.00633	0.00633	CcSEcCtD
Agomelatine—Dyspepsia—Chlorambucil—testicular cancer	0.00609	0.00609	CcSEcCtD
Agomelatine—Eye disorder—Ifosfamide—testicular cancer	0.00602	0.00602	CcSEcCtD
Agomelatine—Tinnitus—Ifosfamide—testicular cancer	0.00601	0.00601	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Chlorambucil—testicular cancer	0.00597	0.00597	CcSEcCtD
Agomelatine—Fatigue—Chlorambucil—testicular cancer	0.00597	0.00597	CcSEcCtD
Agomelatine—Hepatobiliary disease—Cisplatin—testicular cancer	0.00585	0.00585	CcSEcCtD
Agomelatine—Paraesthesia—Vinblastine—testicular cancer	0.00569	0.00569	CcSEcCtD
Agomelatine—Phosphatase alkaline increased—Epirubicin—testicular cancer	0.00568	0.00568	CcSEcCtD
Agomelatine—Infestation NOS—Etoposide—testicular cancer	0.00567	0.00567	CcSEcCtD
Agomelatine—Infestation—Etoposide—testicular cancer	0.00567	0.00567	CcSEcCtD
Agomelatine—Gastrointestinal pain—Chlorambucil—testicular cancer	0.00566	0.00566	CcSEcCtD
Agomelatine—Mental disorder—Ifosfamide—testicular cancer	0.00564	0.00564	CcSEcCtD
Agomelatine—Abnormal dreams—Epirubicin—testicular cancer	0.00561	0.00561	CcSEcCtD
Agomelatine—Jaundice—Etoposide—testicular cancer	0.00553	0.00553	CcSEcCtD
Agomelatine—Urticaria—Chlorambucil—testicular cancer	0.0055	0.0055	CcSEcCtD
Agomelatine—Abdominal pain—Chlorambucil—testicular cancer	0.00547	0.00547	CcSEcCtD
Agomelatine—Connective tissue disorder—Cisplatin—testicular cancer	0.00546	0.00546	CcSEcCtD
Agomelatine—Constipation—Vinblastine—testicular cancer	0.00542	0.00542	CcSEcCtD
Agomelatine—Hepatobiliary disease—Etoposide—testicular cancer	0.00536	0.00536	CcSEcCtD
Agomelatine—Infection—Bleomycin—testicular cancer	0.00532	0.00532	CcSEcCtD
Agomelatine—Vision blurred—Ifosfamide—testicular cancer	0.00529	0.00529	CcSEcCtD
Agomelatine—Phosphatase alkaline increased—Doxorubicin—testicular cancer	0.00526	0.00526	CcSEcCtD
Agomelatine—Abnormal dreams—Doxorubicin—testicular cancer	0.00519	0.00519	CcSEcCtD
Agomelatine—Eye disorder—Cisplatin—testicular cancer	0.00519	0.00519	CcSEcCtD
Agomelatine—Gastrointestinal pain—Vinblastine—testicular cancer	0.00519	0.00519	CcSEcCtD
Agomelatine—Tinnitus—Cisplatin—testicular cancer	0.00518	0.00518	CcSEcCtD
Agomelatine—Agitation—Ifosfamide—testicular cancer	0.00515	0.00515	CcSEcCtD
Agomelatine—Angioedema—Ifosfamide—testicular cancer	0.00512	0.00512	CcSEcCtD
Agomelatine—Vertigo—Ifosfamide—testicular cancer	0.00504	0.00504	CcSEcCtD
Agomelatine—Abdominal pain—Vinblastine—testicular cancer	0.00501	0.00501	CcSEcCtD
Agomelatine—Asthenia—Chlorambucil—testicular cancer	0.00496	0.00496	CcSEcCtD
Agomelatine—Infection—Dactinomycin—testicular cancer	0.00496	0.00496	CcSEcCtD
Agomelatine—Hepatic failure—Methotrexate—testicular cancer	0.0049	0.0049	CcSEcCtD
Agomelatine—Pruritus—Chlorambucil—testicular cancer	0.0049	0.0049	CcSEcCtD
Agomelatine—Paraesthesia—Bleomycin—testicular cancer	0.00481	0.00481	CcSEcCtD
Agomelatine—Eye disorder—Etoposide—testicular cancer	0.00476	0.00476	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—testicular cancer	0.00474	0.00474	CcSEcCtD
Agomelatine—Blood alkaline phosphatase increased—Epirubicin—testicular cancer	0.00474	0.00474	CcSEcCtD
Agomelatine—Diarrhoea—Chlorambucil—testicular cancer	0.00473	0.00473	CcSEcCtD
Agomelatine—Hepatic failure—Epirubicin—testicular cancer	0.00459	0.00459	CcSEcCtD
Agomelatine—Eczema—Epirubicin—testicular cancer	0.00459	0.00459	CcSEcCtD
Agomelatine—Vision blurred—Cisplatin—testicular cancer	0.00456	0.00456	CcSEcCtD
Agomelatine—Asthenia—Vinblastine—testicular cancer	0.00455	0.00455	CcSEcCtD
Agomelatine—Infection—Ifosfamide—testicular cancer	0.00455	0.00455	CcSEcCtD
Agomelatine—Tremor—Cisplatin—testicular cancer	0.00453	0.00453	CcSEcCtD
Agomelatine—Nervous system disorder—Ifosfamide—testicular cancer	0.00449	0.00449	CcSEcCtD
Agomelatine—Skin disorder—Ifosfamide—testicular cancer	0.00445	0.00445	CcSEcCtD
Agomelatine—Hyperhidrosis—Ifosfamide—testicular cancer	0.00443	0.00443	CcSEcCtD
Agomelatine—Vomiting—Chlorambucil—testicular cancer	0.0044	0.0044	CcSEcCtD
Agomelatine—Blood alkaline phosphatase increased—Doxorubicin—testicular cancer	0.00439	0.00439	CcSEcCtD
Agomelatine—Diarrhoea—Vinblastine—testicular cancer	0.00434	0.00434	CcSEcCtD
Agomelatine—Fatigue—Dactinomycin—testicular cancer	0.00431	0.00431	CcSEcCtD
Agomelatine—Back pain—Etoposide—testicular cancer	0.00428	0.00428	CcSEcCtD
Agomelatine—Urticaria—Bleomycin—testicular cancer	0.00425	0.00425	CcSEcCtD
Agomelatine—Eczema—Doxorubicin—testicular cancer	0.00425	0.00425	CcSEcCtD
Agomelatine—Hepatic failure—Doxorubicin—testicular cancer	0.00425	0.00425	CcSEcCtD
Agomelatine—Irritability—Methotrexate—testicular cancer	0.00421	0.00421	CcSEcCtD
Agomelatine—Dizziness—Vinblastine—testicular cancer	0.00419	0.00419	CcSEcCtD
Agomelatine—Nausea—Chlorambucil—testicular cancer	0.00411	0.00411	CcSEcCtD
Agomelatine—Paraesthesia—Ifosfamide—testicular cancer	0.00411	0.00411	CcSEcCtD
Agomelatine—Anxiety—Cisplatin—testicular cancer	0.0041	0.0041	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—testicular cancer	0.00409	0.00409	CcSEcCtD
Agomelatine—Gastrointestinal pain—Dactinomycin—testicular cancer	0.00408	0.00408	CcSEcCtD
Agomelatine—Somnolence—Ifosfamide—testicular cancer	0.00407	0.00407	CcSEcCtD
Agomelatine—Migraine—Epirubicin—testicular cancer	0.00406	0.00406	CcSEcCtD
Agomelatine—Vomiting—Vinblastine—testicular cancer	0.00403	0.00403	CcSEcCtD
Agomelatine—Face oedema—Epirubicin—testicular cancer	0.00398	0.00398	CcSEcCtD
Agomelatine—Vertigo—Etoposide—testicular cancer	0.00398	0.00398	CcSEcCtD
Agomelatine—Headache—Vinblastine—testicular cancer	0.00397	0.00397	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.00395	0.00395	CcSEcCtD
Agomelatine—Abdominal pain—Dactinomycin—testicular cancer	0.00395	0.00395	CcSEcCtD
Agomelatine—Fatigue—Ifosfamide—testicular cancer	0.00395	0.00395	CcSEcCtD
Agomelatine—Infection—Cisplatin—testicular cancer	0.00392	0.00392	CcSEcCtD
Agomelatine—Constipation—Ifosfamide—testicular cancer	0.00391	0.00391	CcSEcCtD
Agomelatine—Nervous system disorder—Cisplatin—testicular cancer	0.00387	0.00387	CcSEcCtD
Agomelatine—Asthenia—Bleomycin—testicular cancer	0.00384	0.00384	CcSEcCtD
Agomelatine—Skin disorder—Cisplatin—testicular cancer	0.00383	0.00383	CcSEcCtD
Agomelatine—Hyperhidrosis—Cisplatin—testicular cancer	0.00381	0.00381	CcSEcCtD
Agomelatine—Pruritus—Bleomycin—testicular cancer	0.00379	0.00379	CcSEcCtD
Agomelatine—Nausea—Vinblastine—testicular cancer	0.00377	0.00377	CcSEcCtD
Agomelatine—Migraine—Doxorubicin—testicular cancer	0.00376	0.00376	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.00375	0.00375	CcSEcCtD
Agomelatine—Gastrointestinal pain—Ifosfamide—testicular cancer	0.00374	0.00374	CcSEcCtD
Agomelatine—Nasopharyngitis—Epirubicin—testicular cancer	0.00369	0.00369	CcSEcCtD
Agomelatine—Face oedema—Doxorubicin—testicular cancer	0.00368	0.00368	CcSEcCtD
Agomelatine—Urticaria—Ifosfamide—testicular cancer	0.00364	0.00364	CcSEcCtD
Agomelatine—Abdominal pain—Ifosfamide—testicular cancer	0.00362	0.00362	CcSEcCtD
Agomelatine—Infection—Etoposide—testicular cancer	0.00359	0.00359	CcSEcCtD
Agomelatine—Asthenia—Dactinomycin—testicular cancer	0.00358	0.00358	CcSEcCtD
Agomelatine—Influenza—Epirubicin—testicular cancer	0.00356	0.00356	CcSEcCtD
Agomelatine—Paraesthesia—Cisplatin—testicular cancer	0.00354	0.00354	CcSEcCtD
Agomelatine—Skin disorder—Etoposide—testicular cancer	0.00351	0.00351	CcSEcCtD
Agomelatine—Hyperhidrosis—Etoposide—testicular cancer	0.00349	0.00349	CcSEcCtD
Agomelatine—Diarrhoea—Dactinomycin—testicular cancer	0.00342	0.00342	CcSEcCtD
Agomelatine—Nasopharyngitis—Doxorubicin—testicular cancer	0.00341	0.00341	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Cisplatin—testicular cancer	0.00341	0.00341	CcSEcCtD
Agomelatine—Vomiting—Bleomycin—testicular cancer	0.00341	0.00341	CcSEcCtD
Agomelatine—Infestation NOS—Methotrexate—testicular cancer	0.0034	0.0034	CcSEcCtD
Agomelatine—Infestation—Methotrexate—testicular cancer	0.0034	0.0034	CcSEcCtD
Agomelatine—Depression—Methotrexate—testicular cancer	0.00339	0.00339	CcSEcCtD
Agomelatine—Influenza—Doxorubicin—testicular cancer	0.0033	0.0033	CcSEcCtD
Agomelatine—Asthenia—Ifosfamide—testicular cancer	0.00328	0.00328	CcSEcCtD
Agomelatine—Paraesthesia—Etoposide—testicular cancer	0.00325	0.00325	CcSEcCtD
Agomelatine—Weight increased—Epirubicin—testicular cancer	0.00324	0.00324	CcSEcCtD
Agomelatine—Pruritus—Ifosfamide—testicular cancer	0.00324	0.00324	CcSEcCtD
Agomelatine—Weight decreased—Epirubicin—testicular cancer	0.00322	0.00322	CcSEcCtD
Agomelatine—Somnolence—Etoposide—testicular cancer	0.00321	0.00321	CcSEcCtD
Agomelatine—Hepatobiliary disease—Methotrexate—testicular cancer	0.00321	0.00321	CcSEcCtD
Agomelatine—Nausea—Bleomycin—testicular cancer	0.00318	0.00318	CcSEcCtD
Agomelatine—Infestation—Epirubicin—testicular cancer	0.00318	0.00318	CcSEcCtD
Agomelatine—Infestation NOS—Epirubicin—testicular cancer	0.00318	0.00318	CcSEcCtD
Agomelatine—Vomiting—Dactinomycin—testicular cancer	0.00318	0.00318	CcSEcCtD
Agomelatine—Diarrhoea—Ifosfamide—testicular cancer	0.00313	0.00313	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Etoposide—testicular cancer	0.00312	0.00312	CcSEcCtD
Agomelatine—Fatigue—Etoposide—testicular cancer	0.00312	0.00312	CcSEcCtD
Agomelatine—Jaundice—Epirubicin—testicular cancer	0.0031	0.0031	CcSEcCtD
Agomelatine—Constipation—Etoposide—testicular cancer	0.00309	0.00309	CcSEcCtD
Agomelatine—Hepatitis—Methotrexate—testicular cancer	0.00305	0.00305	CcSEcCtD
Agomelatine—Dizziness—Ifosfamide—testicular cancer	0.00303	0.00303	CcSEcCtD
Agomelatine—Hepatobiliary disease—Epirubicin—testicular cancer	0.00301	0.00301	CcSEcCtD
Agomelatine—Weight increased—Doxorubicin—testicular cancer	0.003	0.003	CcSEcCtD
Agomelatine—Weight decreased—Doxorubicin—testicular cancer	0.00298	0.00298	CcSEcCtD
Agomelatine—Nausea—Dactinomycin—testicular cancer	0.00297	0.00297	CcSEcCtD
Agomelatine—Gastrointestinal pain—Etoposide—testicular cancer	0.00296	0.00296	CcSEcCtD
Agomelatine—Infestation—Doxorubicin—testicular cancer	0.00294	0.00294	CcSEcCtD
Agomelatine—Infestation NOS—Doxorubicin—testicular cancer	0.00294	0.00294	CcSEcCtD
Agomelatine—Vomiting—Ifosfamide—testicular cancer	0.00291	0.00291	CcSEcCtD
Agomelatine—Urticaria—Etoposide—testicular cancer	0.00287	0.00287	CcSEcCtD
Agomelatine—Jaundice—Doxorubicin—testicular cancer	0.00287	0.00287	CcSEcCtD
Agomelatine—Abdominal pain—Etoposide—testicular cancer	0.00286	0.00286	CcSEcCtD
Agomelatine—Hepatitis—Epirubicin—testicular cancer	0.00285	0.00285	CcSEcCtD
Agomelatine—Eye disorder—Methotrexate—testicular cancer	0.00285	0.00285	CcSEcCtD
Agomelatine—Tinnitus—Methotrexate—testicular cancer	0.00284	0.00284	CcSEcCtD
Agomelatine—Asthenia—Cisplatin—testicular cancer	0.00283	0.00283	CcSEcCtD
Agomelatine—Connective tissue disorder—Epirubicin—testicular cancer	0.0028	0.0028	CcSEcCtD
Agomelatine—Hepatobiliary disease—Doxorubicin—testicular cancer	0.00278	0.00278	CcSEcCtD
Agomelatine—Nausea—Ifosfamide—testicular cancer	0.00272	0.00272	CcSEcCtD
Agomelatine—Diarrhoea—Cisplatin—testicular cancer	0.0027	0.0027	CcSEcCtD
Agomelatine—Mental disorder—Methotrexate—testicular cancer	0.00267	0.00267	CcSEcCtD
Agomelatine—Eye disorder—Epirubicin—testicular cancer	0.00267	0.00267	CcSEcCtD
Agomelatine—Tinnitus—Epirubicin—testicular cancer	0.00266	0.00266	CcSEcCtD
Agomelatine—Hepatitis—Doxorubicin—testicular cancer	0.00264	0.00264	CcSEcCtD
Agomelatine—Asthenia—Etoposide—testicular cancer	0.00259	0.00259	CcSEcCtD
Agomelatine—Connective tissue disorder—Doxorubicin—testicular cancer	0.00259	0.00259	CcSEcCtD
Agomelatine—Back pain—Methotrexate—testicular cancer	0.00257	0.00257	CcSEcCtD
Agomelatine—Pruritus—Etoposide—testicular cancer	0.00256	0.00256	CcSEcCtD
Agomelatine—Vomiting—Cisplatin—testicular cancer	0.00251	0.00251	CcSEcCtD
Agomelatine—Vision blurred—Methotrexate—testicular cancer	0.0025	0.0025	CcSEcCtD
Agomelatine—Mental disorder—Epirubicin—testicular cancer	0.0025	0.0025	CcSEcCtD
Agomelatine—Diarrhoea—Etoposide—testicular cancer	0.00247	0.00247	CcSEcCtD
Agomelatine—Eye disorder—Doxorubicin—testicular cancer	0.00247	0.00247	CcSEcCtD
Agomelatine—Tinnitus—Doxorubicin—testicular cancer	0.00246	0.00246	CcSEcCtD
Agomelatine—Back pain—Epirubicin—testicular cancer	0.0024	0.0024	CcSEcCtD
Agomelatine—Dizziness—Etoposide—testicular cancer	0.00239	0.00239	CcSEcCtD
Agomelatine—Vertigo—Methotrexate—testicular cancer	0.00238	0.00238	CcSEcCtD
Agomelatine—Nausea—Cisplatin—testicular cancer	0.00234	0.00234	CcSEcCtD
Agomelatine—Vision blurred—Epirubicin—testicular cancer	0.00234	0.00234	CcSEcCtD
Agomelatine—Mental disorder—Doxorubicin—testicular cancer	0.00231	0.00231	CcSEcCtD
Agomelatine—Vomiting—Etoposide—testicular cancer	0.0023	0.0023	CcSEcCtD
Agomelatine—Agitation—Epirubicin—testicular cancer	0.00228	0.00228	CcSEcCtD
Agomelatine—Headache—Etoposide—testicular cancer	0.00226	0.00226	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.00224	0.00224	CcSEcCtD
Agomelatine—Vertigo—Epirubicin—testicular cancer	0.00223	0.00223	CcSEcCtD
Agomelatine—Back pain—Doxorubicin—testicular cancer	0.00222	0.00222	CcSEcCtD
Agomelatine—Vision blurred—Doxorubicin—testicular cancer	0.00217	0.00217	CcSEcCtD
Agomelatine—Infection—Methotrexate—testicular cancer	0.00215	0.00215	CcSEcCtD
Agomelatine—Nausea—Etoposide—testicular cancer	0.00215	0.00215	CcSEcCtD
Agomelatine—Nervous system disorder—Methotrexate—testicular cancer	0.00212	0.00212	CcSEcCtD
Agomelatine—Agitation—Doxorubicin—testicular cancer	0.00211	0.00211	CcSEcCtD
Agomelatine—Anxiety—Epirubicin—testicular cancer	0.00211	0.00211	CcSEcCtD
Agomelatine—Skin disorder—Methotrexate—testicular cancer	0.0021	0.0021	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.0021	0.0021	CcSEcCtD
Agomelatine—Hyperhidrosis—Methotrexate—testicular cancer	0.00209	0.00209	CcSEcCtD
Agomelatine—Dry mouth—Epirubicin—testicular cancer	0.00207	0.00207	CcSEcCtD
Agomelatine—Vertigo—Doxorubicin—testicular cancer	0.00206	0.00206	CcSEcCtD
Agomelatine—Infection—Epirubicin—testicular cancer	0.00201	0.00201	CcSEcCtD
Agomelatine—Nervous system disorder—Epirubicin—testicular cancer	0.00199	0.00199	CcSEcCtD
Agomelatine—Skin disorder—Epirubicin—testicular cancer	0.00197	0.00197	CcSEcCtD
Agomelatine—Hyperhidrosis—Epirubicin—testicular cancer	0.00196	0.00196	CcSEcCtD
Agomelatine—Insomnia—Methotrexate—testicular cancer	0.00196	0.00196	CcSEcCtD
Agomelatine—Anxiety—Doxorubicin—testicular cancer	0.00195	0.00195	CcSEcCtD
Agomelatine—Paraesthesia—Methotrexate—testicular cancer	0.00194	0.00194	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.00194	0.00194	CcSEcCtD
Agomelatine—Somnolence—Methotrexate—testicular cancer	0.00193	0.00193	CcSEcCtD
Agomelatine—Dry mouth—Doxorubicin—testicular cancer	0.00191	0.00191	CcSEcCtD
Agomelatine—Dyspepsia—Methotrexate—testicular cancer	0.00191	0.00191	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Methotrexate—testicular cancer	0.00187	0.00187	CcSEcCtD
Agomelatine—Fatigue—Methotrexate—testicular cancer	0.00187	0.00187	CcSEcCtD
Agomelatine—Infection—Doxorubicin—testicular cancer	0.00186	0.00186	CcSEcCtD
Agomelatine—Nervous system disorder—Doxorubicin—testicular cancer	0.00184	0.00184	CcSEcCtD
Agomelatine—Insomnia—Epirubicin—testicular cancer	0.00183	0.00183	CcSEcCtD
Agomelatine—Skin disorder—Doxorubicin—testicular cancer	0.00182	0.00182	CcSEcCtD
Agomelatine—Paraesthesia—Epirubicin—testicular cancer	0.00182	0.00182	CcSEcCtD
Agomelatine—Hyperhidrosis—Doxorubicin—testicular cancer	0.00181	0.00181	CcSEcCtD
Agomelatine—Somnolence—Epirubicin—testicular cancer	0.0018	0.0018	CcSEcCtD
Agomelatine—Dyspepsia—Epirubicin—testicular cancer	0.00178	0.00178	CcSEcCtD
Agomelatine—Gastrointestinal pain—Methotrexate—testicular cancer	0.00177	0.00177	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Epirubicin—testicular cancer	0.00175	0.00175	CcSEcCtD
Agomelatine—Fatigue—Epirubicin—testicular cancer	0.00175	0.00175	CcSEcCtD
Agomelatine—Constipation—Epirubicin—testicular cancer	0.00173	0.00173	CcSEcCtD
Agomelatine—Urticaria—Methotrexate—testicular cancer	0.00172	0.00172	CcSEcCtD
Agomelatine—Abdominal pain—Methotrexate—testicular cancer	0.00171	0.00171	CcSEcCtD
Agomelatine—Insomnia—Doxorubicin—testicular cancer	0.0017	0.0017	CcSEcCtD
Agomelatine—Paraesthesia—Doxorubicin—testicular cancer	0.00168	0.00168	CcSEcCtD
Agomelatine—Somnolence—Doxorubicin—testicular cancer	0.00167	0.00167	CcSEcCtD
Agomelatine—Gastrointestinal pain—Epirubicin—testicular cancer	0.00166	0.00166	CcSEcCtD
Agomelatine—Dyspepsia—Doxorubicin—testicular cancer	0.00165	0.00165	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.00162	0.00162	CcSEcCtD
Agomelatine—Fatigue—Doxorubicin—testicular cancer	0.00162	0.00162	CcSEcCtD
Agomelatine—Urticaria—Epirubicin—testicular cancer	0.00161	0.00161	CcSEcCtD
Agomelatine—Constipation—Doxorubicin—testicular cancer	0.0016	0.0016	CcSEcCtD
Agomelatine—Abdominal pain—Epirubicin—testicular cancer	0.0016	0.0016	CcSEcCtD
Agomelatine—Asthenia—Methotrexate—testicular cancer	0.00155	0.00155	CcSEcCtD
Agomelatine—Gastrointestinal pain—Doxorubicin—testicular cancer	0.00153	0.00153	CcSEcCtD
Agomelatine—Pruritus—Methotrexate—testicular cancer	0.00153	0.00153	CcSEcCtD
Agomelatine—Urticaria—Doxorubicin—testicular cancer	0.00149	0.00149	CcSEcCtD
Agomelatine—Abdominal pain—Doxorubicin—testicular cancer	0.00148	0.00148	CcSEcCtD
Agomelatine—Diarrhoea—Methotrexate—testicular cancer	0.00148	0.00148	CcSEcCtD
Agomelatine—Asthenia—Epirubicin—testicular cancer	0.00145	0.00145	CcSEcCtD
Agomelatine—Pruritus—Epirubicin—testicular cancer	0.00143	0.00143	CcSEcCtD
Agomelatine—Dizziness—Methotrexate—testicular cancer	0.00143	0.00143	CcSEcCtD
Agomelatine—Diarrhoea—Epirubicin—testicular cancer	0.00139	0.00139	CcSEcCtD
Agomelatine—Vomiting—Methotrexate—testicular cancer	0.00138	0.00138	CcSEcCtD
Agomelatine—Headache—Methotrexate—testicular cancer	0.00136	0.00136	CcSEcCtD
Agomelatine—Asthenia—Doxorubicin—testicular cancer	0.00135	0.00135	CcSEcCtD
Agomelatine—Dizziness—Epirubicin—testicular cancer	0.00134	0.00134	CcSEcCtD
Agomelatine—Pruritus—Doxorubicin—testicular cancer	0.00133	0.00133	CcSEcCtD
Agomelatine—Vomiting—Epirubicin—testicular cancer	0.00129	0.00129	CcSEcCtD
Agomelatine—Nausea—Methotrexate—testicular cancer	0.00129	0.00129	CcSEcCtD
Agomelatine—Diarrhoea—Doxorubicin—testicular cancer	0.00128	0.00128	CcSEcCtD
Agomelatine—Headache—Epirubicin—testicular cancer	0.00127	0.00127	CcSEcCtD
Agomelatine—Dizziness—Doxorubicin—testicular cancer	0.00124	0.00124	CcSEcCtD
Agomelatine—Nausea—Epirubicin—testicular cancer	0.0012	0.0012	CcSEcCtD
Agomelatine—Vomiting—Doxorubicin—testicular cancer	0.00119	0.00119	CcSEcCtD
Agomelatine—Headache—Doxorubicin—testicular cancer	0.00117	0.00117	CcSEcCtD
Agomelatine—Nausea—Doxorubicin—testicular cancer	0.00111	0.00111	CcSEcCtD
